TY - JOUR
T1 - COVID-19
T2 - Staging of a New Disease
AU - Cordon-Cardo, Carlos
AU - Pujadas, Elisabet
AU - Wajnberg, Ania
AU - Sebra, Robert
AU - Patel, Gopi
AU - Firpo-Betancourt, Adolfo
AU - Fowkes, Mary
AU - Sordillo, Emilia
AU - Paniz-Mondolfi, Alberto
AU - Gregory, Jill
AU - Krammer, Florian
AU - Simon, Viviana
AU - Isola, Luis
AU - Soon-Shiong, Patrick
AU - Aberg, Judith A.
AU - Fuster, Valentin
AU - Reich, David L.
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/11/9
Y1 - 2020/11/9
N2 - Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.
AB - Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.
UR - http://www.scopus.com/inward/record.url?scp=85093943936&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2020.10.006
DO - 10.1016/j.ccell.2020.10.006
M3 - Comment/debate
C2 - 33086031
AN - SCOPUS:85093943936
SN - 1535-6108
VL - 38
SP - 594
EP - 597
JO - Cancer Cell
JF - Cancer Cell
IS - 5
ER -